I
INBX
Inhibrx Biosciences Inc
67.13
+4.78+7.67%After Hours: 67.13 0.00 0.00%16:10 04/08 EDT
OPEN/PREV CLOSE67.87/62.35
TODAY RANGE65.38-71.00
VOL334.20K
MARKET CAP980.57M
52 WEEK RANGE10.81-94.57
AVG VOL (3M)201.62K
% TURNOVER2.29%
TURNOVER--
P/E (TTM)-7.4231
% RANGE9.01%
EPS(TTM)-9.0434
P/E(FORWARD)-12.2949
P/B122.43
BVPS0.5483
DIVIDEND--
P/S752.58
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP616.10M
SHARES OUTSTANDING14.61M
NEXT EARNINGS05/12-05/18
FREE FLOAT9.18M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·8h ago
Inhibrx gains as Stifel issues new Buy based on lead assets
Reuters·16h ago
U.S. RESEARCH ROUNDUP-3M, CME Group, TransDigm Group
TipRanks·1d ago
Inhibrx initiated with a Buy at Stifel
Seeking Alpha·03/25 13:05
Inhibrx Biosciences FY25 Review: Catalyst-Driven Hold Ahead Of Key 2026 Data
Reuters·03/19 20:09
Inhibrx Biosciences Q4 net loss narrows as expenses fall
Seeking Alpha·03/19 20:01
Inhibrx Biosciences GAAP EPS of -$2.11 misses by $0.03
Reuters·03/19 20:00
INHIBRX Q4 EPS USD -2.11
Reuters·03/19 20:00
INHIBRX REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS
PR Newswire·03/02 21:00
Inhibrx Announces Participation in Upcoming Scientific Conference
TipRanks·02/23 14:33
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
Seeking Alpha·01/13 20:09
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too
Same Industry
Name/Symbol
Change%
Price